

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.46842733 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.41197962 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.36330464 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.95577025 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.95093567 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.73990782 |
| 7 | glutamate secretion (GO:0014047) | 5.54186429 |
| 8 | vocalization behavior (GO:0071625) | 5.43342506 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.32073019 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.30628409 |
| 11 | neuronal action potential propagation (GO:0019227) | 5.22736832 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.21537020 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.98155856 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.79891023 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.74940370 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.73059678 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 4.70133537 |
| 18 | exploration behavior (GO:0035640) | 4.68990549 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.63993249 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.59518067 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.56099179 |
| 22 | protein localization to synapse (GO:0035418) | 4.53899709 |
| 23 | sodium ion export (GO:0071436) | 4.45441290 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.43352153 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 4.42169722 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 4.40208525 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.34222728 |
| 28 | long-term memory (GO:0007616) | 4.32063487 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.31066974 |
| 30 | potassium ion homeostasis (GO:0055075) | 4.21728851 |
| 31 | axon ensheathment in central nervous system (GO:0032291) | 4.20082942 |
| 32 | central nervous system myelination (GO:0022010) | 4.20082942 |
| 33 | cerebellar granule cell differentiation (GO:0021707) | 4.17356562 |
| 34 | postsynaptic membrane organization (GO:0001941) | 4.15938201 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.12294545 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 4.10373091 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.09067098 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.05625289 |
| 39 | amino acid import (GO:0043090) | 4.04956405 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.02391592 |
| 41 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.99793764 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.97615286 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.96494706 |
| 44 | neuronal ion channel clustering (GO:0045161) | 3.89865593 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.87102448 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.81074222 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81010891 |
| 48 | neurotransmitter transport (GO:0006836) | 3.78886881 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.75891192 |
| 50 | neuromuscular process controlling balance (GO:0050885) | 3.74787315 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.74616675 |
| 52 | proline transport (GO:0015824) | 3.74114915 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.71642621 |
| 54 | response to pheromone (GO:0019236) | 3.69525418 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.66376480 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.64717345 |
| 57 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.60662423 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58915503 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.58219958 |
| 60 | neurotransmitter uptake (GO:0001504) | 3.57759746 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.57163913 |
| 62 | activation of protein kinase A activity (GO:0034199) | 3.55984372 |
| 63 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.55680324 |
| 64 | neuromuscular process controlling posture (GO:0050884) | 3.54273574 |
| 65 | regulation of neurotransmitter levels (GO:0001505) | 3.52566998 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.45161613 |
| 67 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.43541310 |
| 68 | cell communication by electrical coupling (GO:0010644) | 3.41521787 |
| 69 | prepulse inhibition (GO:0060134) | 3.41042840 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39030901 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.37689584 |
| 72 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.34162726 |
| 73 | neuromuscular synaptic transmission (GO:0007274) | 3.33893440 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33870100 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 3.33282878 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.32216820 |
| 77 | serotonin metabolic process (GO:0042428) | 3.32161357 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.32131332 |
| 79 | membrane depolarization (GO:0051899) | 3.31001020 |
| 80 | glycine transport (GO:0015816) | 3.28780803 |
| 81 | regulation of dendritic spine development (GO:0060998) | 3.28285214 |
| 82 | long term synaptic depression (GO:0060292) | 3.28211766 |
| 83 | auditory behavior (GO:0031223) | 3.27879012 |
| 84 | presynaptic membrane organization (GO:0097090) | 3.26602704 |
| 85 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26407151 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.26351908 |
| 87 | acidic amino acid transport (GO:0015800) | 3.25849792 |
| 88 | dendrite morphogenesis (GO:0048813) | 3.25433796 |
| 89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.23746911 |
| 90 | synaptic vesicle transport (GO:0048489) | 3.22303434 |
| 91 | establishment of synaptic vesicle localization (GO:0097480) | 3.22303434 |
| 92 | cell differentiation in hindbrain (GO:0021533) | 3.21110358 |
| 93 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.20585995 |
| 94 | chemosensory behavior (GO:0007635) | 3.19684919 |
| 95 | innervation (GO:0060384) | 3.18283375 |
| 96 | presynaptic membrane assembly (GO:0097105) | 3.17873410 |
| 97 | potassium ion import (GO:0010107) | 3.12733504 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 3.12471768 |
| 99 | adult walking behavior (GO:0007628) | 3.11083800 |
| 100 | regulation of synapse maturation (GO:0090128) | 3.10864097 |
| 101 | cellular sodium ion homeostasis (GO:0006883) | 3.10753695 |
| 102 | detection of calcium ion (GO:0005513) | 3.08802844 |
| 103 | response to auditory stimulus (GO:0010996) | 3.08642583 |
| 104 | neuromuscular process (GO:0050905) | 3.08628405 |
| 105 | neuron recognition (GO:0008038) | 3.07899496 |
| 106 | L-amino acid import (GO:0043092) | 3.07521666 |
| 107 | vesicle docking involved in exocytosis (GO:0006904) | 3.06882228 |
| 108 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05728429 |
| 109 | cell communication involved in cardiac conduction (GO:0086065) | 3.05007938 |
| 110 | regulation of synaptic transmission (GO:0050804) | 3.04241523 |
| 111 | behavioral defense response (GO:0002209) | 3.03105535 |
| 112 | behavioral fear response (GO:0001662) | 3.03105535 |
| 113 | primary amino compound metabolic process (GO:1901160) | 3.03034718 |
| 114 | synaptic transmission (GO:0007268) | 3.03029922 |
| 115 | learning (GO:0007612) | 3.02471250 |
| 116 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.02015675 |
| 117 | synapse assembly (GO:0007416) | 3.01643315 |
| 118 | vesicle transport along microtubule (GO:0047496) | 3.01538039 |
| 119 | signal release (GO:0023061) | 3.00530400 |
| 120 | positive regulation of synaptic transmission (GO:0050806) | 3.00359773 |
| 121 | positive regulation of dendritic spine development (GO:0060999) | 2.98835608 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98601297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.04029859 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15065833 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14580448 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08611865 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05021477 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.83003438 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.83003438 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82672175 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.82418071 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.78783176 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63473557 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59065920 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56272957 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55360524 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48024732 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.43262204 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39510554 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33037139 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32019310 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31228937 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26063880 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.25295600 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23151649 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16871289 |
| 25 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.16763909 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95605003 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82997045 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82526003 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80650796 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73680726 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71372291 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66887740 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59515754 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54435497 |
| 35 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37660470 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36397058 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36132462 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35268467 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33920677 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30692610 |
| 41 | AR_19668381_ChIP-Seq_PC3_Human | 1.30528605 |
| 42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30392502 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30346354 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28206514 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27877952 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25929696 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25716279 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21147162 |
| 49 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20902365 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.20419766 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17498974 |
| 52 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17177109 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17059985 |
| 54 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16777547 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16388181 |
| 56 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14800813 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14226512 |
| 58 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12818405 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12267154 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12010648 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10734611 |
| 62 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.10361375 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06379458 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05843341 |
| 65 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05518232 |
| 66 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04445387 |
| 67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04365894 |
| 68 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03737076 |
| 69 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02588289 |
| 70 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02134898 |
| 71 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01593537 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01224190 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99697345 |
| 74 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98527731 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98473750 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98437661 |
| 77 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97807128 |
| 78 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97413657 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97320960 |
| 80 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97253790 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96058869 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95368833 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94663415 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94641072 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94413402 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94014196 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93644911 |
| 88 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93190354 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92973307 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92694522 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92690241 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91239931 |
| 93 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89865698 |
| 94 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87059288 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86440031 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85167106 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85167106 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85148906 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85141163 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84948018 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84550717 |
| 102 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84453823 |
| 103 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.84315763 |
| 104 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84172973 |
| 105 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83969572 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83776089 |
| 107 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83716669 |
| 108 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83337347 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83192740 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82897231 |
| 111 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82674709 |
| 112 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.80947888 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78371858 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.76344178 |
| 115 | * GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.75248453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.11740823 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.43987374 |
| 3 | MP0003880_abnormal_central_pattern | 4.27664384 |
| 4 | MP0004270_analgesia | 3.84094664 |
| 5 | MP0009046_muscle_twitch | 3.78325682 |
| 6 | MP0009745_abnormal_behavioral_response | 3.52139832 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.44911272 |
| 8 | MP0002064_seizures | 3.31799315 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.02513787 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.88989206 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.86724323 |
| 12 | MP0002272_abnormal_nervous_system | 2.83773570 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.76320675 |
| 14 | MP0001486_abnormal_startle_reflex | 2.64197601 |
| 15 | MP0002822_catalepsy | 2.62203171 |
| 16 | MP0008569_lethality_at_weaning | 2.53114475 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.37639030 |
| 18 | MP0002736_abnormal_nociception_after | 2.28231127 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.20939234 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.14285165 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.07636114 |
| 22 | MP0002184_abnormal_innervation | 1.95553971 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.94713099 |
| 24 | MP0001970_abnormal_pain_threshold | 1.91991035 |
| 25 | MP0003329_amyloid_beta_deposits | 1.90402799 |
| 26 | MP0004924_abnormal_behavior | 1.84847544 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.84847544 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.81104568 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.80467501 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.77897188 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.73507039 |
| 32 | MP0003879_abnormal_hair_cell | 1.69494471 |
| 33 | MP0004858_abnormal_nervous_system | 1.67199554 |
| 34 | MP0000778_abnormal_nervous_system | 1.57960881 |
| 35 | MP0004885_abnormal_endolymph | 1.56233521 |
| 36 | MP0000955_abnormal_spinal_cord | 1.55965106 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.50973673 |
| 38 | MP0001984_abnormal_olfaction | 1.50950296 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.49916994 |
| 40 | MP0004147_increased_porphyrin_level | 1.47514781 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.44654698 |
| 42 | MP0003633_abnormal_nervous_system | 1.44553233 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.40369021 |
| 44 | MP0003123_paternal_imprinting | 1.38573935 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.38102274 |
| 46 | MP0004142_abnormal_muscle_tone | 1.27165588 |
| 47 | MP0003631_nervous_system_phenotype | 1.26787557 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.26400222 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.21726338 |
| 50 | MP0003787_abnormal_imprinting | 1.18760942 |
| 51 | MP0008872_abnormal_physiological_respon | 1.15313626 |
| 52 | MP0002152_abnormal_brain_morphology | 1.13959562 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.08131066 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.06971728 |
| 55 | MP0002229_neurodegeneration | 1.06010595 |
| 56 | MP0003632_abnormal_nervous_system | 1.04767627 |
| 57 | MP0004742_abnormal_vestibular_system | 1.03038247 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.02138865 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.00597551 |
| 60 | MP0008874_decreased_physiological_sensi | 0.98544449 |
| 61 | MP0001905_abnormal_dopamine_level | 0.97236026 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.96930846 |
| 63 | MP0003075_altered_response_to | 0.96866781 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.92514634 |
| 65 | MP0003690_abnormal_glial_cell | 0.90585599 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.90151802 |
| 67 | MP0001177_atelectasis | 0.89742277 |
| 68 | MP0002090_abnormal_vision | 0.88451615 |
| 69 | MP0001529_abnormal_vocalization | 0.85872725 |
| 70 | MP0000604_amyloidosis | 0.84915136 |
| 71 | MP0000920_abnormal_myelination | 0.84488334 |
| 72 | MP0000751_myopathy | 0.84462679 |
| 73 | MP0004510_myositis | 0.83129580 |
| 74 | MP0001188_hyperpigmentation | 0.83026036 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.82471319 |
| 76 | MP0004085_abnormal_heartbeat | 0.80952705 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.80362131 |
| 78 | MP0005535_abnormal_body_temperature | 0.79441514 |
| 79 | MP0003634_abnormal_glial_cell | 0.77540161 |
| 80 | MP0004233_abnormal_muscle_weight | 0.76814727 |
| 81 | MP0003283_abnormal_digestive_organ | 0.76807359 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.76712760 |
| 83 | MP0004484_altered_response_of | 0.75973113 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.73950725 |
| 85 | MP0005499_abnormal_olfactory_system | 0.73950725 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.73187707 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.72763135 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.71079407 |
| 89 | MP0010234_abnormal_vibrissa_follicle | 0.69075929 |
| 90 | MP0003121_genomic_imprinting | 0.66896085 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.65907247 |
| 92 | MP0003122_maternal_imprinting | 0.65490994 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.65179843 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.64644348 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.64249703 |
| 96 | MP0004043_abnormal_pH_regulation | 0.62368624 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.61039348 |
| 98 | MP0004130_abnormal_muscle_cell | 0.60976151 |
| 99 | MP0005187_abnormal_penis_morphology | 0.59197648 |
| 100 | MP0001485_abnormal_pinna_reflex | 0.57268442 |
| 101 | MP0010769_abnormal_survival | 0.57039022 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.55609871 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.54608638 |
| 104 | MP0010768_mortality/aging | 0.53656379 |
| 105 | MP0002082_postnatal_lethality | 0.52691935 |
| 106 | MP0010770_preweaning_lethality | 0.52691935 |
| 107 | MP0003861_abnormal_nervous_system | 0.52551254 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.52231738 |
| 109 | MP0000026_abnormal_inner_ear | 0.51261462 |
| 110 | MP0000579_abnormal_nail_morphology | 0.50812716 |
| 111 | MP0003956_abnormal_body_size | 0.49430443 |
| 112 | MP0001943_abnormal_respiration | 0.46217393 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.42646824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.46838656 |
| 2 | Myokymia (HP:0002411) | 7.12372564 |
| 3 | Focal seizures (HP:0007359) | 5.92493445 |
| 4 | Visual hallucinations (HP:0002367) | 5.87470064 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 5.38077584 |
| 6 | Action tremor (HP:0002345) | 5.37788570 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.83563314 |
| 8 | Febrile seizures (HP:0002373) | 4.62466949 |
| 9 | Atonic seizures (HP:0010819) | 4.61552853 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 4.40602583 |
| 11 | Absence seizures (HP:0002121) | 4.26439391 |
| 12 | Broad-based gait (HP:0002136) | 3.98237018 |
| 13 | Dysdiadochokinesis (HP:0002075) | 3.95079930 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.85006743 |
| 15 | Dialeptic seizures (HP:0011146) | 3.79840655 |
| 16 | Poor eye contact (HP:0000817) | 3.76053514 |
| 17 | Impaired smooth pursuit (HP:0007772) | 3.62733161 |
| 18 | Cerebral hypomyelination (HP:0006808) | 3.59696225 |
| 19 | Scanning speech (HP:0002168) | 3.53609619 |
| 20 | Dysmetria (HP:0001310) | 3.52785211 |
| 21 | Dysmetric saccades (HP:0000641) | 3.51340244 |
| 22 | Genetic anticipation (HP:0003743) | 3.44626198 |
| 23 | Depression (HP:0000716) | 3.42281715 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.38252525 |
| 25 | Truncal ataxia (HP:0002078) | 3.36952361 |
| 26 | Impaired social interactions (HP:0000735) | 3.35149495 |
| 27 | Abnormal social behavior (HP:0012433) | 3.35149495 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.29351927 |
| 29 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.27043581 |
| 30 | Intention tremor (HP:0002080) | 3.26971254 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 3.25112940 |
| 32 | Ankle clonus (HP:0011448) | 3.15389323 |
| 33 | Hemiplegia (HP:0002301) | 3.14379113 |
| 34 | Postural instability (HP:0002172) | 3.11906106 |
| 35 | Mutism (HP:0002300) | 3.08687902 |
| 36 | Anxiety (HP:0000739) | 3.07125782 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.03513335 |
| 38 | Papilledema (HP:0001085) | 3.03417826 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.95554180 |
| 40 | Diplopia (HP:0000651) | 2.95554180 |
| 41 | Hemiparesis (HP:0001269) | 2.93425005 |
| 42 | Annular pancreas (HP:0001734) | 2.84269714 |
| 43 | Abnormal eating behavior (HP:0100738) | 2.82068382 |
| 44 | Hyperventilation (HP:0002883) | 2.80249376 |
| 45 | Akinesia (HP:0002304) | 2.78444309 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.77506165 |
| 47 | Sleep apnea (HP:0010535) | 2.71141309 |
| 48 | Status epilepticus (HP:0002133) | 2.67117265 |
| 49 | Amblyopia (HP:0000646) | 2.65530682 |
| 50 | Stereotypic behavior (HP:0000733) | 2.65119044 |
| 51 | Delusions (HP:0000746) | 2.64263163 |
| 52 | Torticollis (HP:0000473) | 2.57050349 |
| 53 | Urinary urgency (HP:0000012) | 2.53963108 |
| 54 | Spastic gait (HP:0002064) | 2.53465523 |
| 55 | Spastic tetraparesis (HP:0001285) | 2.48887012 |
| 56 | Excessive salivation (HP:0003781) | 2.47791997 |
| 57 | Drooling (HP:0002307) | 2.47791997 |
| 58 | Focal dystonia (HP:0004373) | 2.46353644 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45027387 |
| 60 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45027387 |
| 61 | Bradykinesia (HP:0002067) | 2.44621359 |
| 62 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.44269049 |
| 63 | Polyphagia (HP:0002591) | 2.40907941 |
| 64 | CNS hypomyelination (HP:0003429) | 2.38461998 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.35144318 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.34399217 |
| 67 | Impaired vibratory sensation (HP:0002495) | 2.33567144 |
| 68 | Pointed chin (HP:0000307) | 2.33115831 |
| 69 | Megalencephaly (HP:0001355) | 2.32105696 |
| 70 | Choreoathetosis (HP:0001266) | 2.29764389 |
| 71 | EEG with generalized epileptiform discharges (HP:0011198) | 2.28057601 |
| 72 | Abnormality of saccadic eye movements (HP:0000570) | 2.27770836 |
| 73 | Absent speech (HP:0001344) | 2.26040801 |
| 74 | Bundle branch block (HP:0011710) | 2.25588245 |
| 75 | Progressive inability to walk (HP:0002505) | 2.23800803 |
| 76 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22153212 |
| 77 | Gait ataxia (HP:0002066) | 2.21738200 |
| 78 | Abnormality of the corticospinal tract (HP:0002492) | 2.21631856 |
| 79 | Tetraplegia (HP:0002445) | 2.21582356 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.20166868 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.17527196 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.14753324 |
| 83 | Apathy (HP:0000741) | 2.14461772 |
| 84 | Agitation (HP:0000713) | 2.12633377 |
| 85 | Lower limb asymmetry (HP:0100559) | 2.11917492 |
| 86 | Postural tremor (HP:0002174) | 2.09422561 |
| 87 | Craniofacial dystonia (HP:0012179) | 2.08941708 |
| 88 | Generalized myoclonic seizures (HP:0002123) | 2.07275663 |
| 89 | Incomplete penetrance (HP:0003829) | 2.06547649 |
| 90 | Horizontal nystagmus (HP:0000666) | 2.06327687 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.05897001 |
| 92 | Insidious onset (HP:0003587) | 2.04618762 |
| 93 | Termporal pattern (HP:0011008) | 2.04618762 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.03520767 |
| 95 | Limb ataxia (HP:0002070) | 2.00609032 |
| 96 | Obstructive sleep apnea (HP:0002870) | 2.00133094 |
| 97 | Rapidly progressive (HP:0003678) | 1.97487066 |
| 98 | Increased circulating renin level (HP:0000848) | 1.95762307 |
| 99 | Insomnia (HP:0100785) | 1.95583155 |
| 100 | Diminished motivation (HP:0000745) | 1.94889841 |
| 101 | Clonus (HP:0002169) | 1.93815385 |
| 102 | Inappropriate behavior (HP:0000719) | 1.90339815 |
| 103 | Lower limb muscle weakness (HP:0007340) | 1.89697646 |
| 104 | Pheochromocytoma (HP:0002666) | 1.85402363 |
| 105 | Limb dystonia (HP:0002451) | 1.84907704 |
| 106 | Central scotoma (HP:0000603) | 1.82913766 |
| 107 | Spastic tetraplegia (HP:0002510) | 1.82815797 |
| 108 | Rigidity (HP:0002063) | 1.81807654 |
| 109 | Spinal canal stenosis (HP:0003416) | 1.80253980 |
| 110 | Psychosis (HP:0000709) | 1.79985043 |
| 111 | Unsteady gait (HP:0002317) | 1.79843123 |
| 112 | Inability to walk (HP:0002540) | 1.79260347 |
| 113 | Memory impairment (HP:0002354) | 1.78207834 |
| 114 | Resting tremor (HP:0002322) | 1.76642218 |
| 115 | Prolonged QT interval (HP:0001657) | 1.74165136 |
| 116 | Abnormal EKG (HP:0003115) | 1.71572809 |
| 117 | Heart block (HP:0012722) | 1.70935776 |
| 118 | Paraplegia (HP:0010550) | 1.70772817 |
| 119 | Intellectual disability, profound (HP:0002187) | 1.70619049 |
| 120 | Abnormality of the periventricular white matter (HP:0002518) | 1.66909038 |
| 121 | Aqueductal stenosis (HP:0002410) | 1.66661368 |
| 122 | Blue irides (HP:0000635) | 1.65315025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.19360889 |
| 2 | MAP3K9 | 4.14922064 |
| 3 | EPHA4 | 3.94552099 |
| 4 | MAP3K4 | 3.09418500 |
| 5 | DAPK2 | 2.74247367 |
| 6 | MARK1 | 2.69431789 |
| 7 | MINK1 | 2.69008427 |
| 8 | PAK6 | 2.53977416 |
| 9 | MAP2K7 | 2.43010858 |
| 10 | CAMKK1 | 2.40037448 |
| 11 | KSR2 | 2.27452167 |
| 12 | RIPK4 | 2.20098232 |
| 13 | PRKD3 | 2.11424153 |
| 14 | CAMKK2 | 2.03781908 |
| 15 | NTRK2 | 2.03325793 |
| 16 | MAP2K4 | 2.00317310 |
| 17 | CDK19 | 1.79060725 |
| 18 | STK38 | 1.78756755 |
| 19 | KSR1 | 1.64418737 |
| 20 | NTRK1 | 1.63018732 |
| 21 | DAPK1 | 1.55816063 |
| 22 | CDK5 | 1.53134334 |
| 23 | MAP3K12 | 1.52371721 |
| 24 | PRPF4B | 1.48836976 |
| 25 | RIPK1 | 1.45373627 |
| 26 | MAP3K13 | 1.39109645 |
| 27 | GRK5 | 1.30041398 |
| 28 | SIK2 | 1.29103155 |
| 29 | PLK2 | 1.28386131 |
| 30 | ARAF | 1.27255911 |
| 31 | TYRO3 | 1.26201401 |
| 32 | PRKCG | 1.24292967 |
| 33 | TNIK | 1.19308770 |
| 34 | PNCK | 1.18665344 |
| 35 | TAOK1 | 1.13119585 |
| 36 | CAMK1 | 1.12941619 |
| 37 | MAP3K2 | 1.12529136 |
| 38 | FES | 1.08147941 |
| 39 | MAPK13 | 1.06727301 |
| 40 | STK11 | 1.04545509 |
| 41 | PINK1 | 1.04246386 |
| 42 | UHMK1 | 1.03633107 |
| 43 | BMPR2 | 0.98941781 |
| 44 | SGK223 | 0.98615169 |
| 45 | SGK494 | 0.98615169 |
| 46 | CDK18 | 0.98058382 |
| 47 | CDK15 | 0.97928292 |
| 48 | RET | 0.96301366 |
| 49 | PRKCH | 0.95991913 |
| 50 | SGK2 | 0.90942826 |
| 51 | CAMK2A | 0.90849750 |
| 52 | LATS2 | 0.90451510 |
| 53 | CDK14 | 0.89652149 |
| 54 | ALK | 0.89109359 |
| 55 | RAF1 | 0.88560952 |
| 56 | SGK3 | 0.86705181 |
| 57 | CASK | 0.86269223 |
| 58 | CDK11A | 0.85413536 |
| 59 | PDK1 | 0.83991680 |
| 60 | WNK1 | 0.82946351 |
| 61 | PHKG2 | 0.80954550 |
| 62 | PHKG1 | 0.80954550 |
| 63 | OXSR1 | 0.80806060 |
| 64 | PKN1 | 0.74376577 |
| 65 | DYRK1A | 0.73795424 |
| 66 | PTK2B | 0.72951976 |
| 67 | SGK1 | 0.72917360 |
| 68 | FGFR2 | 0.71057854 |
| 69 | CAMK2B | 0.70265608 |
| 70 | PDPK1 | 0.70158944 |
| 71 | LIMK1 | 0.65742929 |
| 72 | MARK2 | 0.63398492 |
| 73 | PAK3 | 0.62765972 |
| 74 | CAMK4 | 0.62521201 |
| 75 | WNK4 | 0.59766982 |
| 76 | NEK1 | 0.57421447 |
| 77 | MAP3K1 | 0.56220734 |
| 78 | CAMK1G | 0.55937658 |
| 79 | LMTK2 | 0.54668477 |
| 80 | MAP3K11 | 0.53807874 |
| 81 | RPS6KA3 | 0.53333177 |
| 82 | CSNK1G2 | 0.52814621 |
| 83 | CDC42BPA | 0.51225346 |
| 84 | MAP3K6 | 0.50946209 |
| 85 | CAMK2G | 0.50087675 |
| 86 | SCYL2 | 0.49767089 |
| 87 | BRAF | 0.48933105 |
| 88 | STK39 | 0.48625727 |
| 89 | FYN | 0.47308180 |
| 90 | MAP3K7 | 0.46853067 |
| 91 | TNK2 | 0.46747101 |
| 92 | PRKCZ | 0.46532599 |
| 93 | CAMK2D | 0.45290329 |
| 94 | NEK6 | 0.43939643 |
| 95 | MAPK10 | 0.42676185 |
| 96 | MAPKAPK5 | 0.39301174 |
| 97 | PRKCA | 0.38381545 |
| 98 | DMPK | 0.38373582 |
| 99 | BRSK1 | 0.36822703 |
| 100 | DAPK3 | 0.35591329 |
| 101 | MOS | 0.34046874 |
| 102 | ROCK2 | 0.34002845 |
| 103 | MAPK12 | 0.32802187 |
| 104 | PRKCE | 0.32577508 |
| 105 | MAP2K1 | 0.31791793 |
| 106 | CCNB1 | 0.31298188 |
| 107 | PRKCB | 0.31175238 |
| 108 | PRKACA | 0.30038907 |
| 109 | PRKG1 | 0.28297927 |
| 110 | ERBB2 | 0.27722521 |
| 111 | CSNK1D | 0.27536591 |
| 112 | MAP2K6 | 0.24953478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73003010 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21024137 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.84101833 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.76178608 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75775165 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72116204 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65404485 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64547655 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.48707113 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42769057 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.28463683 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26191136 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11159161 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.99139526 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98090955 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97899666 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.96406508 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92253572 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.74810451 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.70844778 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70066402 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.62762834 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56774807 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55403325 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51390899 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.50244488 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47853498 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46440446 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35407676 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.34346902 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34298233 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30557371 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29849010 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27599714 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25738545 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21124310 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20002120 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.14069860 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12255731 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10351020 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.05469091 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02842784 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00599534 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00562207 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98245276 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.96393858 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95853235 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91783536 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91691788 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91581769 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.85244037 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84976063 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84213335 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80551115 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79896759 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78535189 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75249982 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71385035 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71236488 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70815511 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70071263 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67647287 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67043464 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66152796 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65449096 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62805002 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59173226 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.57810582 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56832316 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56475189 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56367877 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55928289 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53422975 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51839967 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51367735 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50439286 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.50405522 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47277833 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46340793 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.46078420 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.44971448 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44563859 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44463082 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43364858 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42109386 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40686632 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40607917 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40280650 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39354011 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39276976 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38749423 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35888339 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35632559 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35292718 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34337563 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34118558 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33612945 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33414155 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33176667 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32947919 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30711115 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.29709411 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28795187 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28349722 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28147546 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27641760 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.26441675 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25447357 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24502983 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24135028 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22485224 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.18570242 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.16962748 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13940417 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.13131818 |

